Process for removing cobalt, lead, cadmium and chromium ions from bodily fluids using metallate ion exchange compositions

US11964266B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11964266-B2
Application numberUS-201916506377-A
CountryUS
Kind codeB2
Filing dateJul 9, 2019
Priority dateJul 9, 2019
Publication dateApr 23, 2024
Grant dateApr 23, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for removing Co 2+ , Pb 2+ , Cd 2+ and Cr 3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: A m Zr a Ti b Sn c M d Si x O y . A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

First claim

Opening claim text (preview).

We claim as our invention: 1. A process for removing Co 2+ , Pb 2+ , Cd 2+ , Cr 2+ toxins or mixtures thereof from bodily fluids comprising contacting said bodily fluid containing the toxins with an ion exchanger to remove the toxins from the fluid by ion exchange between said ion exchanger and said bodily fluid, the ion exchanger selected from zirconium metallate, titanium metallate, tin metallate, multinary metallate containing more than one of zirconium, titanium and tin, and mixtures thereof, the metallates respectively having an empirical formula on an anhydrous basis of: A m Zr a Ti b Sn c M d Si x O y where A is an exchangeable cation comprising potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, M is at least one framework metal selected from the group consisting of hafnium (4+) or niobium (5+), “m” is a mole ratio of A to total metal (total metal=Zr+Ti+Sn+M) and has a value from 0.10 to 15, “a” is a mole fraction of total metal that is Zr and has a value from zero to 1, “b” is a mole fraction of total metal that is Ti and has a value from zero to 1, “c” is a mole fraction of total metal that is Sn and has a value from zero to 1, where a+b+c >0, “d” is a mole fraction of total metal that is M and has a value from zero to less than 1, where a+b+c+d=1 and, “x” is a mole ratio of Si to total metal and has a value from 0 to 12, and “y” is a mole ratio of O to total metal and has a value from 2.1 to 33. 2. The process of claim 1 wherein the bodily fluid is selected from the group consisting of whole blood, blood plasma, or other component of blood, gastrointestinal fluids and dialysate solution containing blood, blood plasma, other component of blood or gastrointestinal fluids. 3. The process of claim 1 where M is hafnium (+4) or niobium. 4. The process of claim 1 where x=0. 5. The process of claim 1 where a +c+d=0. 6. The process of claim 1 where A is a mixture of calcium and sodium. 7. The process of claim 1 wherein the ion exchanger is packed into hollow fibers incorporated into a membrane. 8. The process of claim 1 wherein said ion exchanger is contained on particles coated with a coating comprising a cellulose derivative composition. 9. The process of claim 1 wherein said process is a hemoperfusion process wherein said bodily fluid is passed through a column containing said ion exchanger. 10. The process of claim 1 wherein a dialysate solution is introduced into a peritoneal cavity and then is flowed through at least one adsorbent bed containing at least one of said ion exchanger. 11. The process of claim 1 wherein said ion exchanger is formed into a shaped article to be ingested orally, followed by ion exchange between said ion exchanger and said Co 2+ , Pb 2+ , Cd 2+ , Cr 2+ toxins contained in a gastrointestinal fluid in a mammal's intestines and then by excretion of said ion exchanger containing said toxins. 12. The process of claim 11 wherein said shaped article is coated with a coating that is not dissolved by conditions within a stomach.

Assignees

Inventors

Classifications

  • B01J39/02Primary

    Processes using inorganic exchangers · CPC title

  • with dialysate regeneration · CPC title

  • Dialysates therefor · CPC title

  • Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents · CPC title

  • by absorption (A61M1/3675 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11964266B2 cover?
A process for removing Co 2+ , Pb 2+ , Cd 2+ and Cr 3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The …
Who is the assignee on this patent?
Uop Llc
What technology area does this patent fall under?
Primary CPC classification B01J39/02. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).